A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.17637 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Mahnaz Shafaei Fallah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran. Hauptthemen laut MEDLINE: Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Proteus Infections, Proteus. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Multidrug-resistant (MDR) bacteria like Proteus species have led to more prolonged hospitalizations, fewer care choices, higher treatment costs, and even death. The present study aims to evaluate the prevalence of MDR Proteus species in clinical samples and to suggest the best therapeutic options for the MDR Proteus species. Methodology: Clinical samples were collected randomly from five hospitals in Golestan Province, Iran, from February 2017 to July 2019. Disk diffusion on Mueller–Hinton agar plates were used to perform antibiotic susceptibility testing (ASTs). By using a double-disc synergy test (DDST), isolates resistant to one of the third-generation cephalosporins were examined for phenotypic extended-spectrum β-lactamase (ESBL) development. A combined double disk synergy test (CDDST) was used to identify MBL-producing isolates.
Results
61 Proteus isolates, including P. Mirabilis 44/61 (77.04%), P. vulgaris 7/61 (11.47%), P. hauseri 5/61 (8.19%), and P. penneri 2/61 (3.27%) were collected. Most of the isolates were obtained from urine samples. P. hauseri isolates were more frequent in females. Resistance to tetracycline and nitrofurantoin antibiotics was observed in most Proteus isolates. P. penneri isolates were all resistant to antibiotics. ESBL production was observed in five ceftazidime-resistant isolates (p < 0.05).
Conclusions
Cefepime and imipenem were found to have the lowest occurrence of antibiotic resistance among Proteus species, confirming that cefepime and imipenem can be used to treat Proteus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
- Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
- Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Fallah, M. S., Razavi Nikoo, H., Jamali, A., Mohebbi, A., & Ghaemi, E. A. (2024). A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.17637
Vancouver
Fallah MS, Razavi Nikoo H, Jamali A, Mohebbi A, Ghaemi EA. A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.17637
BibTeX
@article{Fallah2024,
author = {Fallah, Mahnaz Shafaei and Razavi Nikoo, Hadi and Jamali, Aylar and Mohebbi, Alireza and Ghaemi, Ezzat Allah},
title = {A cross-sectional study on the prevalence of multidrug-resistant clinical isolates of Proteus species in Northern Iran},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.17637}
}
EUVIMED